Treatment (T) | Challenge (C) | Lymphocyte, % | IgA, mg/dL | IgG, mg/dL | IgM, mg/dL |
---|---|---|---|---|---|
CON | NE- | 71.3 | 2.00 | 4.75 | 2.00 |
STB | NE- | 71.0 | 1.25 | 4.75 | 1.75 |
CB | NE- | 72.6 | 1.75 | 4.25 | 1.75 |
CON | NE +  | 72.4 | 1.25 | 2.00 | 1.25 |
STB | NE +  | 72.7 | 1.25 | 3.75 | 1.25 |
CB | NE +  | 72.5 | 1.50 | 3.75 | 1.50 |
SEM2 | Â | 1.44 | 0.332 | 0.663 | 0.326 |
Treatment | |||||
 CON |  | 71.9 | 1.63 | 3.38 | 1.63 |
 STB |  | 71.8 | 1.63 | 4.25 | 1.50 |
 CB |  | 72.6 | 1.50 | 4.00 | 1.63 |
 | Challenge |  |  |  |  |
 |   NE- | 71.6 | 1.83 | 4.58a | 1.83 |
 |   NE+  | 72.5 | 1.33 | 3.17b | 1.33 |
P-value | |||||
 T |  | 0.85 | 0.91 | 0.42 | 0.92 |
 C |  | 0.44 | 0.08 | 0.02 | 0.08 |
 T × C |  | 0.83 | 0.76 | 0.23 | 0.76 |